Physician profile
Schubert Perotte
NPI 1992752331
$13,159.56
in general payments reported to CMS, 2019-2025
15 companies · $293 in 2025
The $293 reported for 2025 was more than what 88% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $240 · 2021: $767 · 2022: $3,556 · 2023: $571 · 2024: $7,523 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,710 · Food and Beverage: $1,621 · Travel and Lodging: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,710.00 |
| Food and Beverage | $1,621.03 |
| Travel and Lodging | $1,055.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $10,243.53 | 2021-2024 | Veklury |
| Astrazeneca Pharmaceuticals LP | $1,289.72 | 2019-2024 | Andexxa |
| Csl Behring | $232.70 | 2021-2025 | Kcentra |
| Inari Medical, INC. | $191.11 | 2022 | |
| Janssen Pharmaceuticals, INC | $185.39 | 2019-2022 | |
| Stryker Corporation | $171.89 | 2025 | Flowtriever |
| Abbvie INC. | $162.82 | 2021-2023 | |
| Heartflow, INC. | $127.28 | 2024 | |
| Alexion Pharmaceuticals, INC. | $125.00 | 2021 | |
| Bioxcel Therapeutics, INC. | $124.61 | 2023 | Igalmi |
| Chiesi USA, INC. | $123.44 | 2021 | |
| Ceribell, INC. | $113.50 | 2024 | Pocket Eeg Device |
| Mindray Ds USA, INC. | $33.01 | 2024 | Te X, Te7 Max |
| Merz North America, INC. | $21.87 | 2023 | Xeomin |
| Ethicon US, LLC | $13.69 | 2025 | Surgicel Nu-Knit, Dermabond Prineo, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Schubert Perotte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.